134 related articles for article (PubMed ID: 37208828)
1. Overexpression of heat shock protein 90 through the downregulation of miR-9-5p in extramammary Paget's disease.
Ohnuma T; Mijiddorj MT; Kajihara I; Sawamura S; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Makino K; Aoi J; Masuguchi S; Fukushima S
J Dermatol; 2023 Sep; 50(9):1216-1221. PubMed ID: 37208828
[TBL] [Abstract][Full Text] [Related]
2. miR-31 is distinctively overexpressed in primary male extramammary Paget's disease.
Guo H; Qi RQ; Lv YN; Wang HX; Hong YX; Zheng S; Li JH; Gao XH; Chen HD
Oncotarget; 2016 Apr; 7(17):24559-63. PubMed ID: 27016415
[TBL] [Abstract][Full Text] [Related]
3. MiR-155, a potential serum marker of extramammary Paget's disease.
Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome sequencing reveals a lncRNA-mRNA interaction network in extramammary Paget's disease.
Zheng DC; Shen YT; Wei ZW; Wan X; Xie MK; Yao HJ; Wang Z
BMC Med Genomics; 2021 Dec; 14(1):291. PubMed ID: 34895219
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
8. Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease.
Kang Z; Jiang L; Chen D; Yan G; Zhang G; Lai Y; Zeng Q; Wang X
Skin Res Technol; 2023 Oct; 29(10):e13497. PubMed ID: 37881057
[TBL] [Abstract][Full Text] [Related]
9. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
10. Intratumor dihydropyrimidine dehydrogenase mRNA expression levels are decreased in extramammary Paget's disease.
Nakamura Y; Kajihara I; Yamada-Kanazawa S; Maeda-Otsuka S; Johno T; Aoi J; Igata T; Masuguchi S; Fukushima S; Jinnin M; Ihn H
Drug Discov Ther; 2017 Jul; 11(3):152-155. PubMed ID: 28603180
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
13. The Warburg effect and tumour immune microenvironment in extramammary Paget's disease: overexpression of lactate dehydrogenase A correlates with immune resistance.
Urata K; Kajihara I; Miyauchi H; Mijiddorj T; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanemaru H; Kanazawa-Yamada S; Makino K; Aoi J; Makino T; Fukushima S; Komohara Y; Ihn H
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1715-1721. PubMed ID: 31838771
[TBL] [Abstract][Full Text] [Related]
14. Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget's Disease.
Urano-Takaoka M; Sumida H; Miyagawa T; Awaji K; Nagai K; Omatsu J; Miyake T; Sato S
Acta Derm Venereol; 2022 Jan; 102():adv00636. PubMed ID: 34904690
[TBL] [Abstract][Full Text] [Related]
15. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target.
Nakamura Y; Mizukami H; Tanese K; Fusumae T; Hirai I; Amagai M; Takamatsu R; Nakamura K; Nishihara H; Takimoto T; Ueno M; Saya H; Funakoshi T
J Dermatol Sci; 2023 Oct; 112(1):23-30. PubMed ID: 37661472
[TBL] [Abstract][Full Text] [Related]
16. Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Arita T; Kondo J; Kaneko Y; Tsutsumi M; Kanemaru M; Matsui M; Arakawa Y; Katoh N; Inoue M; Asai J
J Dermatol Sci; 2020 Sep; 99(3):185-192. PubMed ID: 32800410
[TBL] [Abstract][Full Text] [Related]
17. Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease.
Kang Z; Xu F; Zhang QA; Lin J; Wu Z; Zhang X; Luo Y; Xu J; Guan M
Mod Pathol; 2012 Aug; 25(8):1160-8. PubMed ID: 22522847
[TBL] [Abstract][Full Text] [Related]
18. PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease.
Matsumura Y; Matsumura Y; Nishigori C; Horio T; Miyachi Y
Int J Cancer; 2004 Aug; 111(2):218-23. PubMed ID: 15197774
[TBL] [Abstract][Full Text] [Related]
19. Mammary and Extramammary Paget's Disease Presented Different Expression Pattern of Steroid Hormone Receptors.
Zhou S; Zhong W; Mai R; Zhang G
Biomed Res Int; 2017; 2017():3768247. PubMed ID: 29082243
[TBL] [Abstract][Full Text] [Related]
20. Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.
Maeda T; Kitamura S; Nishihara H; Yanagi T
Oncogene; 2020 Sep; 39(36):5867-5875. PubMed ID: 32724160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
